✦ LIBER ✦

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas : An immunohistochemical and fluorescence in situ hybridization study

✍ Scribed by Shioto Suzuki; Yoh Dobashi; Hiroyuki Sakurai; Keiichi Nishikawa; Mitsuhiko Hanawa; Akishi Ooi

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 211 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20909

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exclusive mutation in epidermal growth f

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

✍ Makoto Suzuki; Hisayuki Shigematsu; Toshihiko Iizasa; Kenzo Hiroshima; Yukio Nak 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views

Comparative analysis of epidermal growth

Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer

✍ Takashi Sone; Kazuo Kasahara; Hideharu Kimura; Kazuto Nishio; Masayuki Mizuguchi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 1 views

## Abstract ## BACKGROUND. Because the investigation of epidermal growth factor receptor gene (__EGFR__) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated __EGFR__ mutations and gene amplification in biopsy specimens from Japanese patients wi

Expression of syndecan-1 and expression

Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma

✍ Lori Shah; Kristin L. Walter; Alain C. Borczuk; Steven M. Kawut; Joshua R. Sonet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND Recently, the authors identified molecular signatures and pathways associated with nonsmall cell lung carcinoma histology and lung development. They hypothesized that genetic classifiers of histology would provide insight into lung tumorigenesis and would be associated wi

Novel microdeletion in the transforming

Novel microdeletion in the transforming growth factor β type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma

✍ Jiu-Cun Wang; Cheng-Chang Su; Ji-Bin Xu; Le-Zhen Chen; Xiao-Hua Hu; Gui-Ying Wan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB 👁 1 views

## Abstract Mutations in the tumor suppressor gene transforming growth factor β (TGFB) Type II receptor (__TGFBR2__) are frequently found in many cancers with microsatellite instability, but are less common in lung cancer. In the present study, we looked for mutations in __TGFBR2__ in nonsmall cell

Epidermal growth factor receptor immunoh

Epidermal growth factor receptor immunohistochemistry : Comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer

✍ Fred R. Hirsch; Rafal Dziadziuszko; Nick Thatcher; Helen Mann; Claire Watkins; D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## BACKGROUND The ISEL (Iressa Survival Evaluation in Lung Cancer) clinical trial evaluated the efficacy of gefitinib versus placebo in pretreated nonsmall‐cell lung cancer patients. Two different antibodies, scoring systems, and cutoff points of epidermal growth factor receptor (EGFR)